Stay hydrated with drinks such as water, fruit juices (unless they cause nausea), and broth Eat smaller, more frequent meals, instead of larger meals
It reduces joint pain
Clinical trials of FDA-approved semaglutide and tirzepatide show the difference clearly: Semaglutide patients lose about 15% of total body weight Tirzepatide patients lose approximately 21% Both medications can cause mild gastrointestinal side effects, but tirzepatide is often better tolerated, with many patients reporting fewer symptoms
Biomarker screening and genetic predisposition assessment should complementnot replacecomprehensive medical evaluation
Considering the relationship between GLP-1 signaling and behavioral symptoms characteristic of depression, it was shown that intracerebroventricular ( icv ) administration of both GLP-1 and exendin-4 enhances associative and spatial learning, while these effects are inhibited by a GLP-1R antagonist
Animal studies show reduced binge-eating behavior by 50%